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Abstract

Purpose:
Ethanol serves as a solvent and microbial preservative in oral liquid medications and is the second most commonly used solvent in liquid medications following water. Despite widespread use of ethanol in liquid medications for neonates, the pharmacokinetics and toxicity of ethanol in young children are not well described. The aim of the current study is to quantify blood ethanol levels in neonates secondary to oral ethanol containing medications.
Methods:
Neonates who received either oral phenobarbital (15% ethanol) and/or oral dexamethasone (30% ethanol) per standard of care were eligible for enrollment. A maximum of 6 blood samples per patient (4.5 mL total) were taken over the study period. Blood samples were collected via heel stick at the time of clinical laboratory collections or following a specific collection for study purposes. In addition, blood samples were collected from neonates receiving sublingual buprenorphine (30% ethanol) for neonatal abstinence syndrome from a separate clinical study. Blood ethanol levels were measured using a validated headspace gas chromatography-mass spectrometry method utilizing micro-volume ( ̴ 100uL) plasma samples. The limit of detection and lower limit of quantification for the assay were 0.1 mg/L and 0.5 mg/L respectively.
Results:
A total of 39 plasma samples from 15 neonates who were on ethanol containing medications were collected over the study period. Four neonates were exposed to phenobarbital and/or dexamethasone, while eleven neonates were exposed to buprenorphine alone or in combination with phenobarbital. Patients were exposed to an average of 71.6 mg/kg (range 13.1 to 215 mg/kg) of ethanol after a single dose of an ethanol containing medication. Blood ethanol levels were detectable in 98% (38/39) of samples, quantifiable in 67% (26/39) of samples, and ranged from below detection to 85.4 mg/L. Ethanol was rapidly cleared and did not accumulate with current dosing regimens.
Conclusion:
Ethanol intake secondary to medication administration varied widely. Blood ethanol levels in neonates were low and ethanol was eliminated rapidly after a single dose of oral medications that contained a sizable fraction of ethanol. 
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Samples were collected from two populations:
• Study #1: Neonates (n=3) who received either oral phenobarbital (15% ethanol, q12hr) and/or oral dexamethasone (30% ethanol, q12hr) per standard of care were eligible for enrollment. A maximum of 6 blood samples/patient were taken over the study period. Blood samples were collected via heel stick at the time of clinical laboratory collections or following a specific collection for study purposes.
• Inclusion Criteria: age <1 year, on any oral ethanol containing medication
• Study #2: Neonates receiving sublingual buprenorphine (n=12, 30% ethanol, q8hr) or morphine (n=14, control, no ethanol) for neonatal abstinence syndrome (NAS) from a separate clinical study (NCT01452789).
• Inclusion Criteria: ≥37 weeks gestation, exposure to opiates in utero, signs and symptoms of NAS requiring treatment
• Blood ethanol levels were measured using a validated headspace gas chromatography-mass spectrometry method utilizing micro-volume ( ̴ 100uL) plasma samples. The limit of detection (LOD) and lower limit of quantification (LLOQ) for the assay were 0.1 mg/L and 0.5 mg/L respectively.
• Ethanol intake secondary to medication administration varied widely, but was generally low • Endogenous ethanol generation is present in non-ethanol treated infants (43% of samples ≥LLOQ)
• Blood ethanol levels in neonates were low and ethanol was eliminated rapidly after a single dose of oral medications that contained a sizable fraction of ethanol -All blood ethanol levels were below the American Academy of Pediatrics recommendation following a single dose of an ethanol containing medication -Approximately one third of blood ethanol levels were above the European Medicines Agency recommendation following a single dose of an ethanol containing medication • Develop a population pharmacokinetic model to describe ethanol pharmacokinetics • Approximately one third (13/39) of the blood alcohol levels were below the lower limit of quantification • 80% of the samples had detectable blood ethanol levels (≥LOD)
• 43% of the samples had quantifiable blood ethanol levels (≥LLOQ) 
